Dose predictions for [177Lu]Lu-DOTA-panitumumab F(ab′)2 in NRG mice with HNSCC patient-derived tumour xenografts based on [64Cu]Cu-DOTA-panitumumab F(ab′)2 – implications for a PET theranostic strategy
| Autor: | Ku, Anthony1 (AUTHOR), Kondo, Misaki1 (AUTHOR), Cai, Zhongli1 (AUTHOR), Meens, Jalna2 (AUTHOR), Li, Min Rong1 (AUTHOR), Ailles, Laurie2,3 (AUTHOR), Reilly, Raymond M.1,2,4,5 (AUTHOR) raymond.reilly@utoronto.ca |
|---|---|
| Zdroj: | EJNMMI Radiopharmacy & Chemistry. 8/12/2021, Vol. 6 Issue 1, p1-22. 22p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|